Update of pathophysiology and treatment options of seborrheic keratosis.


Journal

Dermatologic therapy
ISSN: 1529-8019
Titre abrégé: Dermatol Ther
Pays: United States
ID NLM: 9700070

Informations de publication

Date de publication:
12 2022
Historique:
revised: 13 09 2022
received: 03 08 2022
accepted: 05 10 2022
pubmed: 14 10 2022
medline: 21 12 2022
entrez: 13 10 2022
Statut: ppublish

Résumé

Seborrheic keratosis (SK) is a common, benign tumor that can occur on everybody site and can be conservatively managed. Cosmetic concerns, especially when a lesion involves the facial area, are the most common reason for excision. SK shows male gender preponderance and increasing age is an independent association with the condition. Even though more prevalent in the elderly, it has also been reported in younger age groups like adolescents and young adults. Precise pathogenesis is still obscure, but ultra-violet exposure represents a predisposing factor to SK by altering the biochemical concentration and expression of factors like Glutamine deaminases, endothelin, and stem cell factor. Moreover, the accumulation of amyloid-associated protein has also been postulated. Involvement of genitalia has been associated with human papillomavirus infection. Recently, Merkel cell polyomavirus nucleic acid was also detected in SK. Several oncogenic mutations involving FGFR-3 and FOXN1 have been identified. SKs are usually classified clinically and histologically. Dermatoscopy is a noninvasive alternative diagnostic technique widely used in differentiating SK from other benign and malignant tumors. In terms of treatment, topical agents, shave dissection, cryosurgery, electrodesiccation, laser application and curettage under local anesthesia are safe methods for eradication of SKs, mostly for cosmetic purposes. Though generally safe, the latter techniques may occasionally cause post-procedure depigmentation, scarring, and recurrence. Nanosecond-pulsed electric field technology is a promising new technique with fewer side-effects.

Identifiants

pubmed: 36226729
doi: 10.1111/dth.15934
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e15934

Informations de copyright

© 2022 The Authors. Dermatologic Therapy published by Wiley Periodicals LLC.

Références

Kao S, Kiss A, Efimova T, Friedman AJ. Managing seborrheic keratosis: evolving strategies and optimal therapeutic outcomes. J Drugs Dermatol. 2018;17(9):933-940.
Karadag AS, Parish LC. The status of the seborrheic keratosis. Clin Dermatol. 2018;36(2):275-277. doi:10.1016/j.clindermatol.2017.09.011
Naciri I, Ismaili N. Kératoses séborrhéiques géantes de siège inhabituel [Unusual location of giant seborrhoeic keratoses]. Pan Afr Med J. 2017;25(28):72. doi:10.11604/pamj.2017.28.72.13766
Wollina U. Recent advances in managing and understanding seborrheic keratosis. F1000Res. 2019 Aug 28;8:F1000 Faculty Rev-1520. doi: 10.12688/f1000research.18983.1. PMID: 31508199.
Myroshnychenko MS, Moiseienko TM, Torianyk II, et al. Seborrheic keratosis: current STATE of the problem. Wiad Lek. 2022;75(1 pt 2):172-175. PMID: 35182117.
Hafner C, Vogt T. Seborrheic keratosis. J Dtsch Dermatol Ges. 2008 Aug;6(8):664-677. English, German. doi:10.1111/j.1610-0387.2008.06788.x
Yeatman JM, Kilkenny M, Marks R. The prevalence of seborrhoeic keratoses in an Australian population: does exposure to sunlight play a part in their frequency? Br J Dermatol. 1997;137(3):411-414.
Alapatt GF, Sukumar D, Bhat MR. A Clinicopathological and Dermoscopic correlation of seborrheic keratosis. Indian J Dermatol. 2016;61(6):622-627. doi:10.4103/0019-5154.193667
Xie F, Wang R, Chen Y, et al. A case of Seborrhoeic keratosis and family survey. West Indian Med J. 2015;65(1):219-221. doi:10.7727/wimj.2014.221
Kwon OS, Hwang EJ, Bae JH, et al. Seborrheic keratosis in the Korean males: causative role of sunlight. Photodermatol Photoimmunol Photomed. 2003;19(2):73-80. doi:10.1034/j.1600-0781.2003.00025.x
Kennedy C, Bajdik CD, Willemze R, De Gruijl FR, Bouwes Bavinck JN. Leiden skin cancer study. The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer. J Invest Dermatol. 2003;120(6):1087-1093. doi:10.1046/j.1523-1747.2003.12246.x
Cheong KA, Lee AY. Guanine deaminase stimulates ultraviolet-induced keratinocyte senescence in Seborrhoeic keratosis via guanine metabolites. Acta Derm Venereol. 2020;100(8):adv00109. doi:10.2340/00015555-3473
Serre C, Busuttil V, Botto JM. Intrinsic and extrinsic regulation of human skin melanogenesis and pigmentation. Int J Cosmet Sci. 2018;40(4):328-347. doi:10.1111/ics.12466
Tournoy J, Bossuyt X, Snellinx A, et al. Partial loss of presenilins causes seborrheic keratosis and autoimmune disease in mice. Hum Mol Genet. 2004;13(13):1321-1331. doi:10.1093/hmg/ddh151
Wollina U, Chokoeva A, Tchernev G, Heinig B, Schönlebe J. Anogenital giant seborrheic keratosis. G Ital Dermatol Venereol. 2017;152(4):383-386. doi:10.23736/S0392-0488.16.04945-2
Hillen LM, Rennspiess D, Speel EJ, Haugg AM, Winnepenninckx V, Zur Hausen A. Detection of Merkel cell polyomavirus in seborrheic keratosis. Front Microbiol. 2018;9(8):2648. doi:10.3389/fmicb.2017.02648
Agustí Martínez J, Bella-Navarro R, García-García AB, et al. Familial seborrhoeic keratosis associated with multiple ‘pure reticulated acanthomas’ and infundibulocystic basal cell carcinomas. Br J Dermatol. 2017;177(6):1654-1663. doi:10.1111/bjd.15736
Mandinova A, Kolev V, Neel V, et al. A positive FGFR3/FOXN1 feedback loop underlies benign skin keratosis versus squamous cell carcinoma formation in humans. J Clin Invest. 2009;119(10):3127-3137. doi:10.1172/JCI38543 Erratum in: J Clin Invest 2010;120(2):6455. Pazin, Mike [corrected to Pazin, Michael J]. PMID: 19729838; PMCID: PMC2752067.
Hafner C, Toll A, Fernández-Casado A, et al. Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumors. Proc Natl Acad Sci USA. 2010;107(48):20780-20785. doi:10.1073/pnas.1008365107
Heidenreich B, Denisova E, Rachakonda S, et al. Genetic alterations in seborrheic keratoses. Oncotarget. 2017;8(22):36639-36649. doi:10.18632/oncotarget.16698
Komalasari DN, Djawad K, Nurdin AR, Paturusi II. Unusual clinical manifestation of seborrheic keratosis on the scalp successfully treated with topical trichloroacetic acid: an atypical case report. Pan Afr Med J. 2020;28(37):98. doi:10.11604/pamj.2020.37.98.26090
Phulari RG, Buddhdev K, Rathore R, Patel S. Seborrheic keratosis. J Oral Maxillofac Pathol. 2014;18(2):327-330. doi:10.4103/0973-029X.140926
Hafner C, Landthaler M, Mentzel T, Vogt T. FGFR3 and PIK3CA mutations in stucco keratosis and dermatosis papulosa nigra. Br J Dermatol. 2010;162(3):508-512. doi:10.1111/j.1365-2133.2009.09488.x
Sun MD, Halpern AC. Advances in the etiology, detection, and clinical Management of Seborrheic Keratoses. Dermatology. 2022;238(2):205-217. doi:10.1159/000517070
Battistella M, Peltre B, Cribier B. Composite tumors associating trichoblastoma and benign epidermal/follicular neoplasm: another proof of the follicular nature of inverted follicular keratosis. J Cutan Pathol. 2010;37(10):1057-1063.
Ruhoy SM, Thomas D, Nuovo GJ. Multiple inverted follicular keratoses as a presenting sign of Cowden's syndrome: case report with human papillomavirus studies. J Am Acad Dermatol. 2004;51(3):411-415.
Yoon JH, Baek EJ, Park EJ, Kim KH. Comparative study of treatment methods for benign lichenoid keratosis of the face. Dermatol Ther. 2022;5:e15419.
Ray A, Panda M, Samant S, Mohanty P. A rare case of inverted follicular keratosis in an elderly male: Dermoscopic and histopathological overview with therapeutic response to imiquimod. Indian J Dermatol Venereol Leprol. 2021;1:1-4.
Park JB, Jung JH, Kwon DI, Seong SH, Suh KS, Jang MS. 25036 Dermoscopic features of large cell acanthoma. J Am Acad Dermatol. 2021;85(3):AB52.
Khalili M, Meymandi SS, Amiri R, Aflatoonian M, Alimortazavi S. Clinicopathological evaluation of seborrheic keratosis lesions in patients referred to Afzalipour hospital, Kerman, Iran. Journal of skin and stem. Cell. 2022;9(1):e122310.
Gao YY, An XJ, Yang J, Huang CZ, Tao J. Seborrheic keratosis mimicking basal cell carcinoma under dermoscopy: a case report. Chin Med J (Engl). 2020;133(17):2139-2140.
Richey JD, Deng AC, Dresser K, O'Donnell P, Cornejo KM. Distinguishing between irritated seborrheic keratosis and squamous cell carcinoma in situ using BCL-2 and IMP3 immunohistochemistry. J Cutan Pathol. 2018;45(8):603-609.
Requena L, Kutzner H. Seborrheic keratosis with pseudorosettes and adamantinoid seborrheic keratosis: two new histopathologic variants. J Cutan Pathol. 2006;33(Suppl 2):42-45. doi:10.1111/j.1600-0560.2006.00528.x
Noiles K, Vender R. Are all seborrheic keratoses benign? Review of the typical lesion and its variants. J Cutan Med Surg. 2008;12(5):203-210. doi:10.2310/7750.2008.07096
Mansur AT, Yildiz S. A diagnostic challenge: inflamed and pigmented seborrheic keratosis. Clinical, dermoscopic, and histopathological correlation. Dermatol Online J. 2019;25(3).
Rajesh G, Thappa DM, Jaisankar TJ, Chandrashekar L. Spectrum of seborrheic keratoses in south Indians: a clinical and dermoscopic study. Indian J Dermatol Venereol Leprol. 2011;77(4):483-488. doi:10.4103/0378-6323.82408
Wood LD, Stucki JK, Hollenbeak CS, Miller JJ. Effectiveness of cryosurgery vs curettage in the treatment of seborrheic keratoses. JAMA Dermatol. 2013;149(1):108-109. doi:10.1001/2013.jamadermatol.275
Zaresharifi S, Robati RM, Dadkhahfar S, Forouzanfar MM, Zaresharifi N. Efficacy and safety of cryotherapy, electrodesiccation, CO2 laser, and Er:YAG laser in the treatment of seborrheic keratosis. Dermatol Ther. 2021;34(5):1-7. doi:10.1111/dth.15083
Tran M, Richer V. Elective treatment of dermatosis papulosa nigra: a review of treatment modalities. Skin Therapy Lett. 2020;25(4): 1-5.
Baumann LS, Blauvelt A, Draelos ZD, et al. Safety and efficacy of hydrogen peroxide topical solution, 40%(w/w), in patients with seborrheic keratoses: results from 2 identical, randomized, double-blind, placebo-controlled, phase 3 studies (A-101-SEBK-301/302). J Am Acad Dermatol. 2018;79(5):869-877.
Wollina U. Seborrheic Keratoses-the Most common benign skin tumor of humans. Clinical presentation and an update on pathogenesis and treatment options. Open Access Macedonian J Med Sci. 2018;6(11):2270.
Gonzalez MC, Ramos VM, Ciriaco-Tan CP. Topical treatments for seborrheic keratosis: a systematic review. Acta Med Philipp. 2020;54(3):305-312.
Hruza GJ, Zelickson BD, Selim MM, et al. Safety and efficacy of nanosecond pulsed electric field treatment of seborrheic Keratoses. Dermatol Surg. 2020;46(9):1183-1189. doi:10.1097/DSS.0000000000002278
Ranasinghe GC, Friedman AJ. Managing seborrheic keratoses: evolving strategies for optimizing patient outcomes. J Drugs Dermatol. 2017;16(11):1064-1068.
Greco MJ, Bhutta BS. Seborrheic keratosis. InStatPearls. Accessed 2021 Aug 11. StatPearls Publishing.
Smith SR, Xu S, Estes E, Shanler SD. Anatomic site-specific treatment response with 40% hydrogen peroxide (w/w) topical formulation for raised seborrheic Keratoses: pooled analysis of data from two phase 3 studies. J Drugs Dermatol. 2018;17(10):1092-1098.
Kao S, Kiss A, Efimova T, Friedman A. Ex vivo evaluation of cytotoxicity and melanocyte viability after A-101 hydrogen peroxide topical solution 40% or cryosurgery treatment in seborrheic keratosis lesions. J Am Acad Dermatol. 2018;79(4):767-768.
Mitsuhashi Y, Kawaguchi M, Hozumi Y, Kondo S. Topical vitamin D3 is effective in treating senile warts possibly by inducing apoptosis. J Dermatol. 2005;32(6):420-423.
Klaus MV, Wehr RF, Rogers RS III, Russell TJ, Krochmal L. Evaluation of ammonium lactate in the treatment of seborrheic keratoses. J Am Acad Dermatol. 1990;22(2):199-203.
Herron MD, Bowen AR, Krueger GG. Seborrheic keratoses: a study comparing the standard cryosurgery with topical calcipotriene, topical tazarotene, and topical imiquimod. Int J Dermatol. 2004;43(4):300-302.
Härtel A, Jung T, Sift CR. Artemether for topical use in patients with seborrhoeic keratosis. Brit J Dermatol. 2018;179(5):1225-1226.
Chun EY, Lee JB, Lee KH. Focal trichloroacetic acid peel method for benign pigmented lesions in dark-skinned patients. Dermatol Surg. 2004;30(4):512-516.
Burkhart CG, Burkhart CN. Use of a keratolytic agent with occlusion for topical treatment of hyperkeratotic seborrheic keratoses. SKINmed: Dermatol Clin. 2008;7(1):15-18.
Lacarrubba F, Nasca MR, Verzì AE, Micali G. A novel topical agent in the treatment of seborrheic keratoses: a proof of concept study by clinical and dermoscopic evaluation. Dermatol Ther. 2017;30(5):e12526.
Tsuji T, Morita A. Giant seborrheic keratosis on the frontal scalp treated with topical fluorouracil. J Dermatol. 1995;22(1):74-75.
Cuevas P, Angulo J, Salguero I, Gimenez-Gallego G. Clearance of seborrhoeic keratoses with topical dobesilate. BMJ Case Rep. 2012;2012:bcr0120125628.
Aktaş H, Ergin C, Keseroğlu HÖ. Diclofenac gel may be a new treatment option for seborrheic keratosis. Indian Dermatol Online J. 2016;7(3):211-212.
Gurel MS, Aral BB. Effectiveness of erbium: YAG laser and cryosurgery in seborrheic keratoses: randomized, prospective intraindividual comparison study. J Dermatol Treat. 2015;26(5):477-480.
Bruscino N, Conti R, Campolmi P, et al. Dermatosis Papulosa Nigra and 10,600-nm CO2 laser, a good choice. J Cosmet Laser Ther. 2014;16(3):114-116.
Piccolo D, Di Marcantonio D, Crisman G, et al. Unconventional use of intense pulsed light. Biomed Res Int. 2014;2014:1-10.
Karadag AS, Ozkanli Ş, Mansuroglu C, Ozlu E, Zemheri E. Effectiveness of the pulse dye laser treatment in a Caucasian women with dermatosis papulosa nigra. Indian J Dermatol. 2015;60(3):321.
Alegre-Sanchez A, Jiménez-Gómez N, Moreno-Arrones ÓM, et al. Treatment of flat and elevated pigmented disorders with a 755-nm alexandrite picosecond laser: clinical and histological evaluation. Lasers Med Sci. 2018;33(8):1827-1831.

Auteurs

Surajit Gorai (S)

Department of Dermatology, Apollo Multispeciality Hospital, Kolkata, West Bengal, India.

Shahzaib Ahmad (S)

King Edward Medical University Lahore, Mayo Hospital Lahore, Lahore, Pakistan.

Syeda Sadia Masood Raza (SSM)

Karachi Medical and Dental College, Karachi, Pakistan.

Hadin Darain Khan (HD)

Shalamar Medical and Dental College, Lahore, Pakistan.

Muhammad Asad Raza (MA)

Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, USA.

Farshid Etaee (F)

Yale School of Medicine, Yale-New Haven Health System, New Haven, Connecticut, USA.

Clay J Cockerell (CJ)

Departments of Dermatology and Pathology, The University of Texas Southwestern Medical Center, Dallas, Texas, Cockerell Dermatopathology, Dallas, Texas, USA.

Zoe Apalla (Z)

Second Dermatology Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Mohamad Goldust (M)

Department of Dermatology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH